Dark chocolate (70% cocoa) attenuates the inflammatory marker TNF-α in patients on hemodialysis

Clin Nutr ESPEN. 2023 Feb:53:189-195. doi: 10.1016/j.clnesp.2022.12.009. Epub 2022 Dec 9.

Abstract

Background: Inflammation and oxidative stress lead to a high risk of cardiovascular disease in patients with chronic kidney disease (CKD). Food rich in polyphenols such as dark chocolate may be an effective strategy to mitigate inflammation and delay CKD complications, outwith sensorial pleasure promotion. The aim of this study was to evaluate the effects of dark chocolate on inflammation and oxidative stress markers in patients with CKD on hemodialysis (HD).

Methods: A clinical trial was carried out with 59 patients who were allocated into the chocolate group [40g of dark chocolate (70% cocoa) offered during HD sessions, 3×/week] or the control group with any intervention for two months. Plasma levels of the inflammatory cytokines TNF-α and IL-6 were evaluated by the ELISA method. Thiobarbituric acid reactive substances such as malondialdehyde (MDA) and LDLox levels were evaluated as lipid peroxidation markers. Routine biochemical parameters were analysed using commercial BioClin® kits.

Results: Thirty-five patients completed the chocolate group (18 men, 53.0 (16) years and 31.0 (39) months on HD) and 11 in the control group (7 men, 48.0 (17.5) years and 44.0 (56.5) months on HD). Regarding the differences between the groups, the patients who received dark chocolate had reduced plasma levels of TNF-α compared to the control (p = 0.008). No significant changes were observed in the oxidative stress parameters evaluated in both groups. Routine biochemical (including phosphorus and potassium levels) and anthropometric parameters and food intake were not changed after the study period.

Conclusion: The intervention with dark chocolate (70% cocoa) for two months reduced the plasma levels of TNF-α in patients with CKD on HD. In addition, it is essential to emphasise that chocolate intake did not increase the plasma levels of phosphorus and potassium in these patients. This study was registered at clinicaltrials.gov as NCT04600258.

Keywords: Chronic kidney disease; Dark chocolate; Hemodialysis; Inflammation; Oxidative stress.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cacao
  • Chocolate*
  • Female
  • Humans
  • Inflammation
  • Male
  • Middle Aged
  • Renal Dialysis*
  • Renal Insufficiency, Chronic*
  • Tumor Necrosis Factor-alpha* / blood

Substances

  • Tumor Necrosis Factor-alpha

Associated data

  • ClinicalTrials.gov/NCT04600258